Emma Pendleton Bradley Hospital

Emma Pendleton Bradley Hospital, operating as Bradley Hospital, is a tax-exempt nonprofit pediatric psychiatric hospital based in Riverside, Rhode Island that serves as a prime recipient on federal research grants, with 61% of recent awards in a prime capacity and 39% as a sub-recipient across the National Institutes of Health and related HHS agencies.

Bradley Hospital's research footprint centers on pediatric mental health, sleep and circadian rhythm disruption, substance use disorders in youth, and the neurobiological effects of early adversity and trauma. The hospital has received $158.4 million in combined obligations across 96 awards since the early 1990s, with recent activity concentrated in NIH grant awards addressing mechanistic and intervention research. Representative prime grant work includes a $7.94 million NIH Office of the Director Construction Support award (CFDA 93.352) for construction and equipping of the Bradley Hospital Integrative Research Laboratories—a 13,856 square-foot facility consolidating sleep and circadian research suites, biomarker and biospecimen assessment laboratories, and specialized physiological laboratories for EEG and neuromodulation research, with performance completion targeted for May 31, 2030. Bradley Hospital also holds a $175,175 National Heart, Lung, and Blood Institute Cardiovascular Diseases Research award (CFDA 93.837) for development and implementation of Nurturing Sleep, a trauma-informed digital sleep intervention for preschoolers in foster care, running through June 30, 2030. A $737,000 National Institute of Mental Health Mental Health Research Grants award (CFDA 93.242) funds investigation of mitochondrial signaling, stress, and sleep in children with internalizing disorders, enrolling 60 children ages 9-12 from Bradley's day hospital program to test cell-free mitochondrial DNA as a biomarker of stress and psychiatric outcomes.

Customer concentration is heavily skewed toward NIMH and the broader National Institutes of Health. The National Institute of Mental Health accounts for 29 awards across the 96-award portfolio; NIH broadly (including component institutes) accounts for approximately 60% of awards. The Health Resources and Services Administration places 7 awards. Sixteen distinct federal agencies have funded Bradley Hospital work, but the concentration within NIMH reflects the hospital's position as a research organization embedded in pediatric psychiatry and neuroscience.

Bradley Hospital's sub-recipient role surfaces partnership relationships with Brown University (sleep assessment consultation, suicide assessment tool development, maternal-child interaction measurement), Butler Hospital (ecological assessment of suicide risk during care transitions, transcranial direct current stimulation for opioid relapse prevention), and Rhode Island Department of Health (home visiting, pediatric mental health access, youth suicide prevention). These sub-awards place Bradley as a clinical site and technical expert contributing sleep, physiological assessment, and recruitment capacity to larger federal-funded research initiatives.

Activity has grown over the past five years—7 awards in 2022 to 20 in 2024—though 2025 and 2026 show moderation at 9 and 8 awards respectively. Eleven awards reach ultimate completion within the next twenty-four months, creating recompete exposure in that window. Bradley Hospital does not hold federal contracts or IDVs; its federal footprint is exclusively grant-based, with awards flowing through CFDA programs for research, health workforce, and facility construction. The hospital competes in full-and-open grant mechanisms typical of NIH and HHS research funding, with no SBA set-aside presence.